1. Home
  2. MBAI vs BNGO Comparison

MBAI vs BNGO Comparison

Compare MBAI & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.62

Market Cap

10.6M

Sector

N/A

ML Signal

N/A

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.14

Market Cap

11.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBAI
BNGO
Founded
2004
2003
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
11.6M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MBAI
BNGO
Price
$1.62
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
161.0K
221.2K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,000,735.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$24.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.26
52 Week Low
$1.31
$1.06
52 Week High
$3.92
$5.50

Technical Indicators

Market Signals
Indicator
MBAI
BNGO
Relative Strength Index (RSI) 47.23 35.69
Support Level $1.31 $1.06
Resistance Level $1.87 $1.64
Average True Range (ATR) 0.16 0.06
MACD -0.02 0.01
Stochastic Oscillator 33.49 43.75

Price Performance

Historical Comparison
MBAI
BNGO

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: